Stephen J.LurieMD, PhD, Contributing EditorIndividualAuthor
Copyright 2000 American Medical Association. All Rights Reserved.
Applicable FARS/DFARS Restrictions Apply to Government Use.2000
To the Editor: The study by Dr Brady and colleagues1 of sertraline treatment of posttraumatic stress
disorder (PTSD) is a welcome addition to the sparse literature on therapeutic
options for this common condition. Moreover, their conclusion that the benefit
of sertraline occurred predominantly within the first 2 to 4 weeks of treatment
may have important clinical implications.
Fontanarosa PB, Krakow B, Hollifield M, Warner TD. Placebo Effect in Posttraumatic Stress Disorders. JAMA. 2000;284(5):563. doi:10.1001/jama.284.5.561